机构:[1]Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan, China[2]Institute of Hepatobiliary, Pancreatic and Intestinal Disease, North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan, China
第一作者机构:[1]Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan, China[2]Institute of Hepatobiliary, Pancreatic and Intestinal Disease, North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan, China
通讯作者:
通讯机构:[1]Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan, China[2]Institute of Hepatobiliary, Pancreatic and Intestinal Disease, North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan, China
推荐引用方式(GB/T 7714):
Chen Jianyu,Liu Zhi,Zhong Yang,et al.Circ_0124208 Promotes the Progression of Hepatocellular Carcinoma by Regulating the miR-338-3p/LAMC1 Axis[J].Molecular biotechnology.2023,doi:10.1007/s12033-023-00686-2.
APA:
Chen Jianyu,Liu Zhi,Zhong Yang,Chen Hui&Xie Liang.(2023).Circ_0124208 Promotes the Progression of Hepatocellular Carcinoma by Regulating the miR-338-3p/LAMC1 Axis.Molecular biotechnology,,
MLA:
Chen Jianyu,et al."Circ_0124208 Promotes the Progression of Hepatocellular Carcinoma by Regulating the miR-338-3p/LAMC1 Axis".Molecular biotechnology .(2023)